I 
117TH CONGRESS 
1ST SESSION H. R. 5592 
To require the head of each Executive agency to submit a report on the 
effects of requiring the employees of such agency to be vaccinated against 
COVID–19, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
OCTOBER 15, 2021 
Mr. JACKSON (for himself, Mr. BURGESS, Mrs. MILLER-MEEKS, and Mr. 
BABIN) introduced the following bill; which was referred to the Com-
mittee on Oversight and Reform 
A BILL 
To require the head of each Executive agency to submit 
a report on the effects of requiring the employees of 
such agency to be vaccinated against COVID–19, and 
for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Forbidding Repressive 
Executive Efforts and Denouncing Overreaching Man-
dates Act’’ or the ‘‘FREEDOM Act’’. 
SEC. 2. SENSE OF CONGRESS. 
Congress finds the following: 
VerDate Sep 11 2014 
00:36 Oct 16, 2021
Jkt 029200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H5592.IH
H5592
kjohnson on DSK79L0C42PROD with BILLS
(1) President Biden’s recent Executive order on 
COVID–19 vaccine mandates is both unconstitu-
tional and a Federal overreach. 
(2) The decision to be vaccinated should only be 
made and known between an individual and his or 
her doctor. 
(3) A Federal COVID–19 vaccine mandate is 
an infringement upon an individual’s freedom, 
rights, and liberty. 
(4) A Federal COVID–19 vaccine mandate does 
not properly consider the strength of natural immu-
nity. 
(5) Individuals, businesses, localities, and 
States should have the personal choice whether or 
not to be vaccinated against COVID–19. 
SEC. 3. REPORT ON FEDERAL EMPLOYEE COVID–19 VAC-
CINATION MANDATE. 
(a) IN GENERAL.—Not later than 90 days after the 
date of the enactment of this Act, the head of each Execu-
tive agency shall submit to Congress— 
(1) a report on the effects of a requirement 
that the employees of such Executive agency be vac-
cinated against the COVID–19 virus, including— 
(A) the estimated number of employees of 
such Executive agency— 
VerDate Sep 11 2014 
00:36 Oct 16, 2021
Jkt 029200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H5592.IH
H5592
kjohnson on DSK79L0C42PROD with BILLS
(i) who do not intend to get vac-
cinated; and 
(ii) who would leave such Executive 
agency due to such a requirement; 
(B) the effects on the workforce of such 
Executive agency and on the ability of such Ex-
ecutive agency to carry out the mission of such 
Executive agency resulting from such employees 
leaving due to such a requirement; 
(C) any plans of such Executive agency to 
mitigate any loss of institutional knowledge re-
sulting from such employees leaving due to such 
a requirement; and 
(D) estimates of how long such Executive 
agency will take to fill the positions left vacant 
by such employees leaving due to such a re-
quirement and the costs of filling such posi-
tions; and 
(2) a certification whether such a requirement 
will adversely affect the ability of such Executive 
agency to carry out the mission of such Executive 
agency. 
(b) DEFINITIONS.—In this Act: 
VerDate Sep 11 2014 
00:36 Oct 16, 2021
Jkt 029200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H5592.IH
H5592
kjohnson on DSK79L0C42PROD with BILLS
(1) EMPLOYEE.—The term ‘‘employee’’ has the 
meaning given such term in section 2105 of title 5, 
United States Code. 
(2) EXECUTIVE AGENCY.—The term ‘‘Executive 
agency’’ has the meaning given such term in section 
105 of title 5, United States Code. 
Æ 
VerDate Sep 11 2014 
00:36 Oct 16, 2021
Jkt 029200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6301
E:\BILLS\H5592.IH
H5592
kjohnson on DSK79L0C42PROD with BILLS